1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002. 165:277–304.
2. Gross TJ, Hunninhake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001. 345:517–525.
3. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol. 1994. 18:136–147.
4. Leslie KO. Historical perspictive: a pathologic approach to the classification of idiopathic interstitial pneumonias. Chest. 2005. 128:513S–519S.
5. Kim DS. An CM, editor. idiopathic interstitial pneumonia. Respiratory diseases. 2004. Seoul: Koonja publishing Inc;457–467.
6. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol. 1996. 149:1241–1256.
7. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992. 7:120–125.
8. Selman M, Ruiz V, Cabrea S, Segura L, Ramirez R, Barrios R, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis: aprevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol. 2000. 279:L562–L574.
9. Fukuda Y, Ishizake M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9, and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab invest. 1998. 78:687–698.
10. Madtes DK, Eliston AL, Kaback LA, Clark JG. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2001. 24:599–607.
11. Choi KH, Lee HB, Jeong MY, Rhee YK, Chung MJ, Kwak YG, et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia. Chest. 2002. 121:1478–1485.
12. Suga M, Iyonaga K, Okamoto T, Gushima Y, Miyakawa H, Akaike T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2000. 162:1949–1956.
13. Park JH, Shim TS, Lim CM, Koh YS, Lee SD, Kim WS, et al. Matrix metalloproteinases in idiopathic pulmonary fibrosis. Tuberc Respir Dis. 2001. 51:303–314.
14. Kyung SY, Lim YH, An CH, Park JW, Jeong SH, Shin EK, et al. Immunohistochemical study of metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1, -2 in idiopathic interstitial pneumonia. Korean J Med. 2003. 65:196–204.
15. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications fortherapy. Ann Intern Med. 2001. 134:136–151.